Eli Lilly to Acquire GC Biopharma’s Curevo Vaccine in Blockbuster $1.5 Billion Deal
GC Biopharma’s U. S. affiliate, Curevo Vaccine, is set to be acquired by global pharmaceutical giant Eli Lilly in a deal valued at up to $1.
Search results for "clinical trial"
Can Guava Juice Fight Anemia? New Study Shows Significant Hemoglobin Boost
Researchers at Aga Khan University in Pakistan recently published a comprehensive analysis evaluating the relationship between guava juice...
Complete Remission in Metastatic Pancreatic Cancer: Nesuparib Shows Early Clinical Promise
Early clinical data point to extended survival and the rare possibility of complete remission in metastatic pancreatic...
High-Dose Vitamin D During Pregnancy Linked to Higher Childhood Memory Scores, But Experts Urge Caution
Children born to mothers who consumed high-dose vitamin D supplements during pregnancy scored higher on memory tests at...
Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?
A Reuters report said the U.K. media outlet The Guardian reported on the 19th (20th in Korea time) that the World...
Unlocking the Science of Self-Care: Actress Jun Ji-hyun Skips Breakfast for Time-Restricted Eating
Actress Jun Ji-hyun (44) recently shared her signature dietary routine for maintaining her iconic physique.
Can Eye Health Be Reversed?... Clues Found to ‘Retinal Rejuvenation’
A potential way to return aged cells in the eye to a more youthful state has been identified.
The Hype vs. Science: Creatine Boosts Muscle Strength, But Anti-Inflammatory Claims Lack Evidence
Creatine supplements have long been a staple in the fitness community, celebrated for their undeniable ability to...
Oscotec Ramps Up R&D: What Lies Beyond the Success of Lazertinib?
“It doesn’t end with lazertinib. Keep an eye out for the next candidate in line.”Oscotec is aggressively channeling the...
Seizure- and Recurrence-Prone Glioma: First New Drug in 20 Years
Being diagnosed with a brain tumor in your 30s or 40s—when you are building your career, raising children, and staying...